Impact of comorbidity on colorectal cancer screening cost-effectiveness study in diabetic populations.

ABSTRACT:

Background

Although comorbidity has been shown to affect the benefits and risks of colorectal cancer (CRC) screening, it has not been accounted for in prior cost-effectiveness analyses of CRC screening.

Objective

To evaluate the impact of diagnosis of diabetes mellitus, a highly prevalent comorbidity in U.S. adults aged 50 and older, on health and economic outcomes of CRC screening.

Design

Cost-effectiveness analysis using an integrated modeling framework.

Data sources

Derived from basic and epidemiologic studies, clinical trials, cancer registries, and a colonoscopy database.

Target population

U.S. 50-year-old population.

Time horizon

Lifetime.

Perspective

Costs are based on Medicare reimbursement rates.

Interventions

Colonoscopy sc

SUBMITTER: Dinh TA 

PROVIDER: S-EPMC3358394 | biostudies-literature | 2012 Jun

REPOSITORIES: biostudies-literature